A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease

Clinical trial NCT06992661 · RECRUITING

Trial details

NCT number: NCT06992661
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Interstitial Lung Disease (ILD)Healthy Volunteers

Start date: 2025-05-15
Primary completion: 2026-12-31
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.